Valente G - Search Results

1

Deletion of the ectodomain unleashes the transforming, invasive, and tumorigenic potential of the MET oncogene.

Merlin S, Pietronave S, Locarno D, Valente G, Follenzi A, Prat M. Merlin S, et al. Among authors: valente g. Cancer Sci. 2009 Apr;100(4):633-8. doi: 10.1111/j.1349-7006.2008.01079.x. Epub 2009 Jan 21. Cancer Sci. 2009. PMID: 19175607

2

The balance between IL-17 and IL-22 produced by liver-infiltrating T-helper cells critically controls NASH development in mice.

Rolla S, Alchera E, Imarisio C, Bardina V, Valente G, Cappello P, Mombello C, Follenzi A, Novelli F, Carini R. Rolla S, et al. Among authors: valente g. Clin Sci (Lond). 2016 Feb;130(3):193-203. doi: 10.1042/CS20150405. Epub 2015 Nov 11. Clin Sci (Lond). 2016. PMID: 26558403

3

The dilemma: does tissue expression of cathepsin D reflect tumor malignancy? The question: does the assay truly mirror cathepsin D mis-function in the tumor?

Nicotra G, Castino R, Follo C, Peracchio C, Valente G, Isidoro C. Nicotra G, et al. Among authors: valente g. Cancer Biomark. 2010;7(1):47-64. doi: 10.3233/CBM-2010-0143. Cancer Biomark. 2010. PMID: 21045264 Review.

4

Co-expression of plexin-B1 and Met in human breast and ovary tumours enhances the risk of progression.

Valente G, Nicotra G, Arrondini M, Castino R, Capparuccia L, Prat M, Kerim S, Tamagnone L, Isidoro C. Valente G, et al. Cell Oncol. 2009;31(6):423-36. doi: 10.3233/CLO-2009-0504. Cell Oncol. 2009. PMID: 19940359 Free PMC article.

5

Adenosine A(2a) receptor stimulation prevents hepatocyte lipotoxicity and non-alcoholic steatohepatitis (NASH) in rats.

Imarisio C, Alchera E, Sutti S, Valente G, Boccafoschi F, Albano E, Carini R. Imarisio C, et al. Among authors: valente g. Clin Sci (Lond). 2012 Sep;123(5):323-32. doi: 10.1042/CS20110504. Clin Sci (Lond). 2012. PMID: 22439844

6

Staging of head and neck squamous cell carcinoma using the MET oncogene product as marker of tumor cells in lymph node metastases.

Cortesina G, Martone T, Galeazzi E, Olivero M, De Stefani A, Bussi M, Valente G, Comoglio PM, Di Renzo MF. Cortesina G, et al. Among authors: valente g. Int J Cancer. 2000 May 20;89(3):286-92. Int J Cancer. 2000. PMID: 10861506

7

Novel mutation in the ATP-binding site of the MET oncogene tyrosine kinase in a HPRCC family.

Olivero M, Valente G, Bardelli A, Longati P, Ferrero N, Cracco C, Terrone C, Rocca-Rossetti S, Comoglio PM, Di Renzo MF. Olivero M, et al. Among authors: valente g. Int J Cancer. 1999 Aug 27;82(5):640-3. doi: 10.1002/(sici)1097-0215(19990827)82:5<640::aid-ijc4>3.0.co;2-6. Int J Cancer. 1999. PMID: 10417759

8

Apocrine carcinoma of the skin. A clinicopathologic, immunocytochemical, and ultrastructural study.

Paties C, Taccagni GL, Papotti M, Valente G, Zangrandi A, Aloi F. Paties C, et al. Among authors: valente g. Cancer. 1993 Jan 15;71(2):375-81. doi: 10.1002/1097-0142(19930115)71:2<375::aid-cncr2820710218>3.0.co;2-4. Cancer. 1993. PMID: 7678545

9

Detection of MET oncogene/hepatocyte growth factor receptor in lymph node metastases from head and neck squamous cell carcinomas.

Galeazzi E, Olivero M, Gervasio FC, De Stefani A, Valente G, Comoglio PM, Di Renzo MF, Cortesina G. Galeazzi E, et al. Among authors: valente g. Eur Arch Otorhinolaryngol. 1997;254 Suppl 1:S138-43. doi: 10.1007/BF02439745. Eur Arch Otorhinolaryngol. 1997. PMID: 9065649

10

Evidence of p53 immunohistochemical overexpression in ethmoidal mucosa of woodworkers.

Valente G, Ferrari L, Kerim S, Gervasio CF, Ricci E, Migliaretti G, Pira E, Bussi M. Valente G, et al. Cancer Detect Prev. 2004;28(2):99-106. doi: 10.1016/j.cdp.2003.12.004. Cancer Detect Prev. 2004. PMID: 15068833

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results